As mentioned previously, commonly used stroke risk stratification tools (i.e., PCE, FSRS) fail to incorporate newer risk markers including pro-BNP and left ventricular hypertrophy, which are associated with increased risk of stroke (24, 25). This evidence concerns the gene NPPB and stroke disorder.